Quotient Technology (QUOT) Misses Q4 EPS by 4c, Slight Beat on Revenues; Offers FY18 Revenue Mid-Point Outlook Above Consensus

Note: EPS may not be comparable

Quotient Technology (NYSE: QUOT) reported Q4 EPS of $0.04, $0.04 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $93.1 million versus the consensus estimate of $92.46 million.

Business Outlook

As of today, Quotient is providing the following business outlook.

For the first quarter 2018, total revenue is expected to be in the range of $83 million to $87 million. Adjusted EBITDA for the first quarter 2018 is expected to be in the range of $11 million to $13 million.

For the full year 2018, total revenue is expected to be in the range of $379 million to $394 million. Adjusted EBITDA for the full year 2018 is expected to be in the range of $65 million to $73 million.

A reconciliation of Adjusted EBITDA, a non-GAAP guidance measure, to a corresponding GAAP measure is not available on a forward-looking basis without unreasonable efforts due to the high variability and low visibility of certain income and expenses items that are excluded in calculating Adjusted EBITDA.

Fourth Quarter 2017 Financial Results

• Total revenue was $93.1 million in Q4 2017, an increase of 23% over Q4 2016.
• Revenues from promotions and media were $63.4 million and $29.7 million, respectively, compared to Q4 2016 revenues of $58.5 million and $16.9 million, respectively.
• GAAP net income for Q4 2017 was $4.2 million, compared to $3.5 million in Q4 2016.
• Adjusted EBITDA was $13.9 million in Q4 2017, an increase of 23% over Q4 2016.
• Transactions totaled 971 million in Q4 2017, up 40% over Q4 2016.

GUIDANCE:

Quotient Technology sees FY2018 revenue of $379-394 million, versus the consensus of $385.92 million.

For earnings history and earnings-related data on Quotient Technology (QUOT) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c